Interested in a
Non-Drug Treatment Option?
In 2017 the FDA approved a new medical device for the acute treatment of migraine.
PRI has been awarded a grant to further evaluate the device.
Qualified participants will be compensated
for time and travel.
Additionally, the first sixty [60!] participants who complete the study successfully will be eligible to receive a new free device.
This study will enroll quickly; if interested,
we encourage you to contact us today!